HLA Typing Market Overview and Introduction

The rising incidents of non-communicable chronic diseases are creating a need for the adoption of treatment measures. Many non-communicable chronic diseases can be successfully treated with organ, tissue, &cell transplantation. The Human Leukocyte Antigen (HLA) test, also referred to as HLA Typing, is conducted to determine tissue compatibility for successful organ transplantation. The test involves matching HLA antigens expressed on the surface of the recipient’s lymphocytes to those of the donor. Based on the similarities, the feasibility of conducting organ transplantation is decided. HLA Typing is often performed for kidneys, bone marrow, liver, pancreas, and heart transplants.

The global HLA typing market is majorly driven by increasing incidents of non-communicable diseases such as chronic kidney diseases, liver cirrhosis, heart diseases, among others. Moreover, the increasing number of organ transplantations, government initiatives promoting organ donation, and technological advancements in the field of diagnostic testing are anticipated to further boost market growth. However, the high costs associated with organ &tissue transplantation are inversely affecting market growth.

The global HLA typing market is segmented into products& services, technology, application, end user and region.

HLA Typing Market By Products& Services

Based on products & services, the HLA typing market can be segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment accounted for the largest market share in 2019 owing to the increasing HLA typing performed prior to organ transplant surgeries. Moreover, the rising molecular techniques in research are as demand consistent supplies of HLA typing reagents and consumables.

HLA Typing Market By Technology

Based on technology, the market can be segmented into molecular assay technologies and non-molecular assay technologies. In terms of market share, the molecular assay technologies segment accounted for the largest market share in 2019. This large share can be attributed to the increasing implementation of molecular techniques for organ compatibility testing. Molecular techniques are more reliable and provide accurate analyses of HLA antigens.

HLA Typing Market By Application

Similarly, in terms of application, the HLA typing market can be segmented into diagnostic applications, infectious disease testing, cancer diagnosis & prevention, and others. The diagnostic applications segment is anticipated to grow at the highest CAGR during the forecast period owing to the increasing histocompatibility testing performed for the diagnosis of infectious diseases and other non-communicable diseases.

HLA Typing Market By End User

Based on end-user, the market is segmented into commercial service providers, hospitals & surgical centers, and research laboratories & academic institutions. The commercial service providers segment is estimated to account for the largest market share owing to the increasing adoption of technologically advanced HLA typing for performing several diagnostic tests by service providers.

HLA Typing Market By Region

The global HLA typing market can be segmented into North America, Europe, Asia Pacific, and the Rest of the World (ROW).North America dominated the market followed by Europe and Asia Pacific. In 2019, North America held the largest market share owing to the increasing adoption of technologically advanced products, several R&D activities performed in this region, and rising incidents of chronic diseases.

HLA Typing Market Prominent Players

Some of the prominent players operating in the global HLA typing market are Thermo Fisher Scientific Inc., Illumina, Inc., QIAGEN, F. Hoffmann-La Roche Ltd, Becton, Dickinson and Company, Immucor, Biofortuna Limited, GenDx, CareDx Inc., and R.O.S.E. GenTec Ltd., among others.